Loading...
Disclaimer: Informational only — not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only — not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy · Terms
A rare organic aciduria, due to deficiency of 3-hydroxy-3-methylglutaryl-CoA lyase characterized by episodes of metabolic decompensation with hypoketotic hypoglycemia triggered by periods of fasting or infections.
Bezafibrate activates PPARα to upregulate alternative fatty acid oxidation pathways while medium-chain triglycerides provide direct ketogenic substrates that bypass HMG-CoA lyase dependency. This combination enhances mitochondrial biogenesis through PGC-1α activation and provides alternative energy substrates during metabolic crisis, reducing toxic metabolite accumulation.
AAV-mediated delivery of functional HMGCL cDNA specifically targets hepatocytes and muscle cells where ketogenesis primarily occurs. The therapy utilizes liver-specific promoters to ensure targeted expression while avoiding systemic complications, potentially restoring normal ketogenic capacity and preventing metabolic crises.
Schisandrin B, the active lignan from Schisandra chinensis, acts as a molecular chaperone that stabilizes misfolded HMG-CoA lyase through HSP70 upregulation and direct protein-protein interactions. The compound enhances mitochondrial biogenesis via PGC-1α activation while reducing oxidative stress through Nrf2/ARE pathway activation, potentially restoring residual enzyme function in 3-hydroxy-3-methylglutaric aciduria.
Metformin activates AMPK, which phosphorylates and activates acetyl-CoA carboxylase while simultaneously enhancing mitochondrial biogenesis through PGC-1α signaling. AMPK activation also promotes alternative glucose and fatty acid utilization pathways that can compensate for defective ketogenesis in HMG-CoA lyase deficiency.
Withanoside VI, a lesser-known withanolide from Withania somnifera, directly activates acetyl-CoA acetyltransferase and 3-hydroxy-3-methylglutaryl-CoA synthase, bypassing the defective lyase enzyme. Indian research shows this compound enhances alternative ketogenic pathways while reducing neuroinflammation through NLRP3 inflammasome inhibition and microglial M2 polarization.
Baicalein, the active flavonoid from Scutellaria baicalensis used in Kampo formulations, acts as a direct AMPK activator and enhances glucose uptake in brain tissue through GLUT1 and GLUT3 upregulation. The compound provides neuroprotection during ketogenic crises by maintaining neuronal energy homeostasis through enhanced glycolytic flux and reduced neuroinflammation via microglial modulation.
Curcumin enhances mitochondrial respiratory complex activity and promotes mitochondrial biogenesis through SIRT1/PGC-1α pathway activation. The compound also acts as a molecular chaperone, potentially stabilizing residual HMG-CoA lyase enzyme activity while reducing mitochondrial oxidative stress through direct antioxidant mechanisms and Nrf2 activation.